FELGNER; Philip L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for FELGNER; Philip L..The latest application filed is for "borrelia diagnostics and screening methods".

Company Profile

0.35.18

FELGNER; Philip L. - Rancho Santa Fe CA
Felgner; Philip L. - Rancho Sante Fe CA
Felgner; Philip L. - San Diego CA
Felgner; Philip L - Rancho Santa Fe CA
Felgner; Philip L. - Rancho Sata Fe CA
Felgner; Philip L. - Palo Alto CA
Felgner; Philip L. - Los Altos CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Borrelia Diagnostics And Screening Methods App 20160195527 - BARBOUR; Alan G. ; et al.	2016-07-07
Borrelia diagnostics and screening methods Grant 9,182,412 - Barbour , et al. November 10, 2	2015-11-10
Immunogenic Plasmodium Falciparum Antigen Compositions And Uses Thereof App 20140348870 - Felgner; Philip L. ; et al.	2014-11-27
Borrelia Diagnostics and Screening Methods App 20130210651 - Barbour; Alan G. ; et al.	2013-08-15
Borrelia diagnostics and screening methods Grant 8,247,181 - Barbour , et al. August 21, 2	2012-08-21
Borrelia Diagnostics And Screening Methods App 20100278866 - Barbour; Alan G. ; et al.	2010-11-04
Methods for treating cancer using interferon-.omega.-expressing polynucleotides Grant 7,470,675 - Horton , et al. December 30, 2	2008-12-30
H3L envelope protein immunization methods and H3L envelope passive protection methods Grant 7,393,533 - Crotty , et al. July 1, 2	2008-07-01
Protein arrays and methods and systems for producing the same Grant 7,319,012 - Felgner , et al. January 15, 2	2008-01-15
Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor App 20070225243 - Horton; Holly ; et al.	2007-09-27
Methods for treating cancer using cytokine-expressing polynucleotides Grant 7,268,120 - Horton , et al. September 11, 2	2007-09-11
Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response Grant 7,250,404 - Felgner , et al. July 31, 2	2007-07-31
Method for generating transcriptionally active DNA fragments App 20060240469 - Liang; Xiaowu ; et al.	2006-10-26
Rapid and enzymeless cloning of nucleic acid fragments App 20050233422 - Liang, Xiaowu ; et al.	2005-10-20
Rapid and enzymeless cloning of nucleic acid fragments Grant 6,936,470 - Liang , et al. August 30, 2	2005-08-30
Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected Grant 6,867,195 - Felgner , et al. March 15, 2	2005-03-15
Expression of exogenous polynucleotide sequences in a vertebrate App 20040132683 - Felgner, Philip L. ; et al.	2004-07-08
Chemical modification of DNA using peptide nucleic acid conjugates Grant 6,746,868 - Felgner , et al. June 8, 2	2004-06-08
Generation of an immune response to a pathogen Grant 6,710,035 - Felgner , et al. March 23, 2	2004-03-23
Expression of exogenous polynucleotide sequences in a vertebrate Grant 6,706,694 - Wolff , et al. March 16, 2	2004-03-16
Expression of exogenous polynucleotide sequences in a vertebrate App 20040023911 - Felgner, Philip L. ; et al.	2004-02-05
Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human Grant 6,673,776 - Felgner , et al. January 6, 2	2004-01-06
Expression of exogenous polynucleotide sequences in a vertebrate App 20030186913 - Wolff, Jon A. ; et al.	2003-10-02
Protein arrays and methods and systems for producing the same App 20030082579 - Felgner, Philip L. ; et al.	2003-05-01
Intracellular protein delivery compositions and methods of use App 20030054007 - Felgner, Philip L. ; et al.	2003-03-20
Rapid and enzymeless cloning of nucleic acid fragments App 20030044820 - Liang, Xiaowu ; et al.	2003-03-06
Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response App 20030032615 - Felgner, Philip L. ; et al.	2003-02-13
Intracellular protein delivery compositions and methods of use App 20030008813 - Felgner, Philip L. ; et al.	2003-01-09
Fast and enzymeless cloning of nucleic acid fragments App 20020165175 - Liang, Xiaowu ; et al.	2002-11-07
Methods of delivering a physiologically active polypeptide to a mammal Grant 6,413,942 - Felgner , et al. July 2, 2	2002-07-02
N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Grant 6,387,395 - Eppstein , et al. May 14, 2	2002-05-14
Method for generating transcriptionally active DNA fragments App 20020037525 - Liang, Xiaowu ; et al.	2002-03-28
Method for generating transcriptionally active DNA fragments Grant 6,280,977 - Liang , et al. August 28, 2	2001-08-28
Stimulating vascular growth by administration of DNA sequences encoding VEGF Grant 6,228,844 - Wolff , et al. May 8, 2	2001-05-08
Induction of a protective immune response in a mammal by injecting a DNA sequence Grant 6,214,804 - Felgner , et al. April 10, 2	2001-04-10
Chemical modification of DNA using peptide nucleic acid conjugates Grant 6,165,720 - Felgner , et al. December 26, 2	2000-12-26
C-reactive protein fragment with immunomodulatory activity Grant 5,783,179 - Nestor, Jr. , et al. July 21, 1	1998-07-21
Generation of antibodies through lipid mediated DNA delivery Grant 5,703,055 - Felgner , et al. December 30, 1	1997-12-30
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal Grant 5,693,622 - Wolff , et al. December 2, 1	1997-12-02
N-[.omega., (.omega.-1)-dialkyloxy]- and N-[.omega., (.omega.-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor Grant 5,622,712 - Eppstein , et al. April 22, 1	1997-04-22
Induction of a protective immune response in a mammal by injecting a DNA sequence Grant 5,589,466 - Felgner , et al. December 31, 1	1996-12-31
Delivery of exogenous DNA sequences in a mammal Grant 5,580,859 - Felgner , et al. December 3, 1	1996-12-03
N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor Grant 5,545,412 - Eppstein , et al. August 13, 1	1996-08-13
Cationic lipids for intracellular delivery of biologically active molecules Grant 5,459,127 - Felgner , et al. October 17, 1	1995-10-17
Vaccine adjuvant Grant 5,376,369 - Allison , et al. December 27, 1	1994-12-27
Cationic lipids for intracellular delivery of biologically active molecules Grant 5,264,618 - Felgner , et al. November 23, 1	1993-11-23
N-(.omega., (.omega.-1)-dialkyloxy)- and N-(.omega., (.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Grant 5,208,036 - Eppstein , et al. May 4, 1	1993-05-04
Liquid single reagent for assays involving confining gels Grant 5,068,198 - Gibbons , et al. November 26, 1	1991-11-26
N-.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor Grant 5,049,386 - Eppstein , et al. September 17, 1	1991-09-17
N-(.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Grant 4,946,787 - Eppstein , et al. August 7, 1	1990-08-07
N[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor Grant 4,897,355 - Eppstein , et al. January 30, 1	1990-01-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.